LLY
Eli Lilly and Company · HAM:LLY
1,275.00 EUR42.80 +3.47%
Eli Lilly and Company (HAM:LLY) last traded at 1,275.00 EUR, up 3.47% on the day. Over the past year the stock is up 82.40%. Its 52-week range is 732.00 to 1,275.00. It is in the Health Technology sector (Pharmaceuticals: Major).
Key statistics
Open1,239.80
Day range1,239.00 – 1,275.00
52-week range732.00 – 1,275.00
Volume4
Average volume (10 days)2
Market cap (USD)1.33 T
P/E47.45
EPS (TTM) (USD)30.44
Dividend yield0.47%
Beta (1 year)0.3795
Revenue (TTM) (USD)86.46 B
Employees50.00 K
Performance
+10.03%1 week
+22.24%1 month
+27.47%3 months
+74.18%6 months
+38.86%Year to date
+82.40%1 year
Technical rating
Strong buy
Daily summary of 11 oscillators and 15 moving averages. See every indicator
Analysts’ target
1,311.77 EUR
The average 1-year price target, +2.88% from the last price. See the forecast
Latest headlines
- Notable healthcare headlines for the week: Eli Lilly, Merck, and AstraZeneca in focusSeeking Alpha · 01 Nov 2026
- Healthcare sector rallies in October amid rotation away from technology stocksSeeking Alpha · 31 Oct 2026
- Healthcare Earnings Scoreboard: 96% beat EPS estimates, 70% post Y/Y earnings growthSeeking Alpha · 31 Oct 2026
- Elon Musk Says Eli Lilly Has ‘Some Banger Drugs Coming Out’ After CEO Dave Ricks Bets Against Vinod Khosla's Big Biotech SkepticismBenzinga · 31 Oct 2026
- Cathie Wood Loads Up On TEM, ILMN And Biotech Stocks — But Pares Stake In This Pharma Giant That Had A Blowout Q3Stocktwits · 31 Oct 2026
- Eli Lilly Is Maintained at Buy by UBSDow Jones Newswires · 31 Oct 2026
- UBS maintains Eli Lilly at Buy, raises price target to $1625 from $1425TradingView · 31 Oct 2026
- What Eli Lilly and Company (LLY) Said on Its Q3 Earnings CallMarketBeat · 30 Oct 2026
Market data from TradingView’s public feed, delayed as the exchange requires. For study only, not investment advice.